nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.12.2010

The Role of NK Cells in the Autoimmune Thyroid Disease-associated Pregnancy Loss

verfasst von: Emiliana Konova

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Pregnancy loss is a frequent event. Autoimmune thyroid disorders and altered natural killer (NK) cell functions are two distinct risk factors, which independently could induce adverse pregnancy outcome. Thyroid autoimmunity has been an object of increased attention by investigators in the context of pregnancy loss. Peripheral NK cells and uNK cells comprise distinct cell populations in terms of phenotype and function but they play an important role in the course of a normal human pregnancy via several potential functions. In autoimmune thyroid diseases, several abnormalities of killer cell activity have been described. The functional defects involving NK maturation and/or functional activation observed in Graves’ disease patients could independently influence the reproductive outcome. This suggestion needs extensive investigation and could be important for the therapeutical approach in preventing pregnancy loss in patients with thyroid autoimmunity.

Еdmonds DK, Lindsay KI, Miller JF (1982) Early embryonic mortality in women. Fertil Steril 38:447–453

Baines MG, Gendron RL (1993) Natural and experimental animal models of reproductive faiture. In: Chaouat G (ed) Immunology of pregnancy. CRC Press, Boca Raton, pp 173–203

Alberman E (1988) The epidemiology of repeated abortion. In: Beard RW, Sharp F (eds) Early pregnancy loss: mechanisms and treatment. Springer-Verlag, New York, pp 9–17

Daya S (2002) Habitual abortion. In: Copeland LJ, Jarell JF (eds) Textbook of gynecology, 2nd edn. W.B. Saunders, Philadelphia, pp 227–271

World Health Organization (1977) Recommended definition, terminology and format for statistical tables related to the perinatal period. Acta Obstet Gynecol Scand 56:247–253

Reiss HE (1998) Reproductive medicine: from A to Z. Oxford University Press, Oxford

Li TC, Makris M, Tomsu M, Tuckerman EM, Laird SM (2002) Recurrent miscarriage, aetiology, management and prognosis. Hum Reprod Update 8:463–481PubMed

Regan L, Rai R (2000) Epidemiology and the medical cause of miscarriage. Bailliere’s Clin Obstet Gynaecol 14:839–854

Clifford K, Rai R, Watson H, Regan L (1994) An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 7:1328–1332

10.

Katz VL, Kuller JA (1994) Recurrent miscarriage. Am J Perinatol 11:386–397PubMed

11.

Stagnaro-Green A, Roman SH, Cobin RH et al (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422–1425PubMed

12.

Pratt D, Novotny M, Kaberlein G, Dudkiewicz A, Gleicher N (1993) Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol 168:837–841PubMed

13.

Bussen S, Steck T (1995) Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum Reprod 10:2938–2940PubMed

14.

Bussen SS, Steck T (1997) Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters). Eur J Obstet Gynecol Reprod Biol 74:139–143PubMed

15.

Esplin MS, Branch DW, Silver R, Stagnaro-Green A (1998) Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol 179:1583–1586PubMed

16.

Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr (1999) Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 71:843–848PubMed

17.

Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G (2000) Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 14:270–274PubMed

18.

Mecacci F, Parretti E, Cioni R et al (2000) Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or preeclampsia. J Reprod Immunol 46:39–50PubMed

19.

Bagis T, Gokcel A, Saygili ES (2001) Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid 11:1049–1053PubMed

20.

Glinoer D, Soto MF, Bourdoux P et al (1991) Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 73:421–427PubMed

21.

Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N (1993) The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril 60:1001–1005PubMed

22.

Lejeune B, Grun JP, de Nayer P, Servais G, Glinoer D (1993) Antithyroid antibodies underlying thyroid abnormalities and miscarriage or pregnancy induced hypertension. Br J Obstet Gynaecol 100:669–672PubMed

23.

Singh A, Dantas ZN, Stone SC, Asch RH (1995) Presence of thyroid antibodies in early reproductive failure: biochemical versus clinical pregnancies. Fertil Steril 63:277–281PubMed

24.

Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N (1997) Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 90:364–369PubMed

25.

Kim CH, Chae HD, Kang BM, Chang YS (1998) Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome. Am J Reprod Immunol 40:2–8PubMed

26.

Muller AF, Verhoeff A, Mantel MJ, Berghout A (1999) Thyroid autoimmunity and abortion: a prospective study in women undergoing in vitro fertilization. Fertil Steril 71:30–34PubMed

27.

Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L (2000) Prospective pregnancy outcome in untreated recurrent miscarries with thyroid autoantibodies. Hum Reprod 15:1637–1639PubMed

28.

Poppe K, Glinoer D, Tournaye H et al (2003) Assisted reproduction and thyroid autoimmunity: an unfortunate combination? J Clin Endocrinol Metab 88:4149–4252PubMed

29.

Prummel MF, Wiersinga WM (2004) Thyroid autoimmunity and miscarriage. Eur J Endocrinol 150:751–755PubMed

30.

Sandercock P (1989) The odds ratio: a useful tool in neurosciences. J Neurol Neurosurg Psychiatry 52:817–820PubMed

31.

Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M (2008) Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract 14:458–464PubMed

32.

Bellver J, Soares SR, Alvarez C et al (2008) The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod 23:278–284PubMed

33.

Kilic S, Tasdemir N, Yilmaz N, Yuksel B, Gul A, Batioglu S (2008) The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynecol Endocrinol 24:649–655PubMed

34.

Stuart AE (1994) Autoantibodies and pregnancy loss. Lancet 343:747–748

35.

Glinoer D (1997) The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18:404–433PubMed

36.

Matalon ST, Blank M, Ornoy A, Shoenfeld Y (2001) The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 45:72–77PubMed

37.

Lazarus JH, Kokandi A (2000) Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol 53:265–278

38.

Menken J, Trussell J, Larsen U (1986) Age and infertility. Science 233:1389–1394PubMed

39.

Matalon ST, Blank M, Levy Y et al (2003) The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod 18:1094–1099PubMed

40.

Lee YL, Ng HP, Lau KS et al (2008) Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril 91(5 Suppl):2104–2109PubMed

41.

Wilson R et al (1999) Thyroid antibody titer and avidity in patients with recurrent miscarriage. Fertil Steril 71:558–561PubMed

42.

Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421–2438PubMed

43.

Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer cell subsets. Trends Immunol 22:633–640PubMed

44.

Naume B, Johnsen AC, Espevik T, Sundan A (1993) Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 23:1831–1838PubMed

45.

Biassoni R, Ferrini S, Prigione I, Pelak VS, Sekaly RP, Long EO (1991) Activated CD3-CD16+ natural killer cells express a subset of the lymphokine genes induced in activated αß + and γδ + T cells. Scand J Immunol 33:247–252PubMed

46.

King A, Allan DS, Bowen M et al (2000) HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol 30:1623–1631PubMed

47.

Lanier LL (2001) On guard—activating NK cell receptors. Nat Immunol 2:23–27PubMed

48.

Gregory CD, Lee H, Rees GB, Scott IV, Shah LP, Golding PR (1985) Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays. Clin Exp Immunol 62:121–127PubMed

49.

Gregory CD, Lee H, Scott IV, Golding PR (1987) Phenotypic heterogeneity and recycling capacity of natural killer cells in normal human pregnancy. J Reprod Immunol 11:135–145PubMed

50.

Ponte M et al (1999) Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 96:5674–5679PubMed

51.

King A (2000) Uterine leukocytes and decidualization. Hum Reprod Update 6:28–36PubMed

52.

Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW (1994) Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 153:4427–4435PubMed

53.

Saito S et al (1993) Cytokine production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Int Immunol 5:559–563PubMed

54.

Koopman LA et al (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198:1201–1212PubMed

55.

Croy BA, Chapeau C (1990) Evaluation of the pregnancy immunotrophism hypothesis by assessment of the reproductive performance of young adult mice of genotype scid/scid.bg/bg. J Reprod Fertil 88:231–239PubMed

56.

Curran EM, Berghaus LJ, Vernetti NJ, Saporita AJ, Lubahn DB, Estes DM (2001) Natural killer cells express estrogen receptor- and estrogen receptor-ß and can respond to estrogen via a non-estrogen receptor-α-mediated pathway. Cell Immunol 214:12–20PubMed

57.

Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO (2003) Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 88:440–449PubMed

58.

Ehring GR et al (1998) A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K + channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 188:1593–1602PubMed

59.

Inoue T et al (1996) Progesterone stimulates the induction of human endometrial CD56+ lymphocytes in an in vitro culture system. J Clin Endocrinol Metab 81:1502–1507PubMed

60.

Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E (2002) Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401–430PubMed

61.

Verma S, Hiby SE, Loke YW, King A (2000) Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 62:959–968PubMed

62.

Kitaya K, Nakayama T, Okubo T, Kuroboshi H, Fushiki S, Honjo H (2003) Expression of macrophage inflammatory protein-1ß in human endometrium: its role in endometrial recruitment of natural killer cells. J Clin Endocrinol Metab 88:1809–1814PubMed

63.

Ntrivalas EI et al (2001) Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 16:855–861PubMed

64.

Aoki K et al (1995) Preconceptional natural killer cell activity as a predictor of miscarriage. Lancet 345:1340–1342PubMed

65.

Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I (2000) Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 15:1163–1169PubMed

66.

Shimada S et al (2004) No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 19:1018–1024PubMed

67.

Lachapelle MH, Miron P, Hemmings R, Roy DC (1996) Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 156:4027–4034PubMed

68.

Clifford K, Flanagan AM, Regan L (1999) Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 14:2727–2730PubMed

69.

Quenby S et al (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 14:2386–2391PubMed

70.

Michimata T et al (2002) Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 47:196–202PubMed

71.

Trinchieri G, Kobayashi M, Seehra J, London L, Perussia B (1984) Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med 160:1147–1169PubMed

72.

Baxter AG, Smyth MJ (2002) The role of NK cells in autoimmune disease. Autoimmunity 35:1–14PubMed

73.

Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG (2002) The natural killer cell—friend or foe in autoimmune disease? Scand J Immunol 55:432–441PubMed

74.

Hauser SL, Ault US, Levin MJ, Garovoy MR, Weiner HL (1981) Natural killer cell activity in multiple sclerosis. J Immunol 127:1114–1117PubMed

75.

Auer IO, Ziemer E, Sommer H (1980) Immune status in Crohn’s disease. Clin Exp Immunol 42:41–47PubMed

76.

Goto M, Tanimoto K, Chihara T, Horiuchi Y (1981) Natural cell-mediated cytotoxicity in Sjogren’s syndrome and rheumatoid arthritis. Arthritis Rheum 24:1377–1382PubMed

77.

Yabuhara A et al (1996) A killing defect of natural killer cells as an underlying immunological abnormality in childhood systemic lupus erythematosus. J Rheumatol 23:171–177PubMed

78.

Smith EM, Phan M, Kruger TE, Coppenhaver DH, Blalock JE (1982) Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci USA 80:6010–6013

79.

Kruger TE, Blalock JE (1986) Cellular requirements for thyrotropin enhancement of in vitro antibody production. J Immunol 137:197–200PubMed

80.

Kruger TE, Smith EM, Harbour DV, Blalock JE (1989) Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol 142:744–747PubMed

81.

Bagriacik EU, Zhou Q, Wang H-C, Klein J (2001) Rapid and transient reduction in circulating thyroid hormones following systemic antigen priming: implications for functional collaboration between dendritic cells and thyroid. Cell Immunol 212:92–100PubMed

82.

Klein JR, Wang H-C (2004) Characterization of a novel set of resident intrathyroidal bone marrow-derived hematopoietic cells: potential for immune-endocrine interactions in thyroid homeostasis. J Exp Biol 207:55–65PubMed

83.

Wang H-C, Dragoo J, Zhou Q, Klein JR (2003) An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells. Blood 101:119–123PubMed

84.

Zhou Q, Wang H-C, Klein JR (2002) Characterization of a novel anti-mouse thyrotropin monoclonal antibody. Hybrid Hybridomics 21:75–79PubMed

85.

Scofield VL, Montufar-Solis D, Cheng E, Estes MK, Klein JR (2005) Intestinal TSH production is localized in villus “hotblocks” and is coupled to IL-7 production: evidence for involvement of TSH during acute virus infection. Immunol Lett 99:36–44PubMed

86.

Klein JR (2006) The immune system as a regulator of thyroid hormone activity. Exp Biol Med 231:229–236

87.

Coutelier JP, Kehrl JH, Bellur SS, Kohn LD, Notkins AL, Prabhakar BS (1990) Binding and functional effects of thyroid stimulating hormone to human immune cells. J Clin Immunol 10:204–210PubMed

88.

Bagriacik EU, Klein JR (2000) The thyrotropin (thyroid stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD43RB^high lymph node T cells: functional role of thyroid stimulating hormone during immune activation. J Immunol 164:6158–6165PubMed

89.

Kruger TE (1996) Immunomodulation of peripheral lymphocytes by hormones of the hypothalamus-pituitary-thyroid axis. Adv Neuroimmunol 6:387–395PubMed

90.

Fabris N, Mochegiani E, Provinciali M (1995) Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine-immune interaction. Horm Res 43:29–38PubMed

91.

Provinciali M, Di Stefano G, Fabris N (1992) Improvement in the proliferative capacity and natural killer cell activity of murine spleen lymphocytes by thyrotropin. Int J Immunopharmacol 14:865–870PubMed

92.

Migita K et al (1989) Cytotoxic activity of interleukin-2 (Il-2) activated killer cells toward thyroid epithelial cells. Clin Exp Immunol 77:196–201PubMed

93.

Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM (1988) Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 318(24):1557–1563PubMed

94.

Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ (2009) Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 160(6):985–991PubMed

95.

Elizabeth N (2008) Association of first trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multi-vitamin use. Endocr Pract 14(1):33–39

96.

Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF (1992) A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 74:645–653PubMed

97.

Casey BM, Dashe JS, Wells CE et al (2005) Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105(2):239–245PubMed

98.

Spencer C, Lee R, Kazarosyan M et al (2005) Thyroid reference ranges in pregnancy: studies on an iodine sufficient cohort. Thyroid 15(1):1–16

99.

Glinoer D, Riahi M, Grün JP, Kinthaert J (1994) Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79:197–204PubMed

100.

Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O (2002) Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12:63–68PubMed

101.

Negro R (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metabol 91(7):2587–2591

102.

Amino N et al (1982) Peripheral K lymphocytes in autoimmune thyroid disease: decrease in Graves’ disease and increase in Hashimoto’s disease. J Clin Endocrinol Metab 54:587–591PubMed

103.

Sawada K, Saturami T, Imura H, Iwamori M, Nabai Y (1980) Anti-asialo-GMI antibody in sera from patients with Graves’ disease and Hashimoto’s thyroiditis [letter]. Lancet 2:198PubMed

104.

Papic M, Stein-Streilein J, Zakarija M, McKenzie JM, Guffee J, Fletcher MA (1987) Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest 79:404–408PubMed

105.

Wang PW, Luo SF, Huang BY, Lin JD, Huang MJ (1988) Depressed natural killer cell activity in Graves’ disease and during antithyroid medication. Clin Endocrinol 28:205–214

106.

Marazuela M, Vargas JA, Alvarez-Mon M, Albarran F, Lucas T, Durantez A (1995) Impaired natural killer cell cytotoxicity in peripheral blood mononuclear cells in Graves’ disease. Eur J Endocrinol 132:175–180PubMed

107.

Calder EA, Irvine WJ, Davidson NM, Wu FT (1976) B and K cells in autoimmune thyroid disease. Clin Exp Immunol 25:17–23PubMed

108.

Tezuka H et al (1988) Natural killer and natural killer-like activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves’ disease. J Clin Endocrinol Metabol 66:702–707

109.

Pedersen BK, Feldt-Rasmussen U, Bech K, Perrild H, Klarlund K, Hoier-Madsen M (1989) Characterization of the natural killer activity in Hashimoto’s and Graves’ diseases. Allergy 44:477–481PubMed

110.

Pruzanski W, Capes H, Baur R, Wenzel BE, Row VV, Volpe R (1984) Biological activity of lymphocytotoxic antibodies in Graves’ disease and Hashimoto’s thyroiditis. J Endocrinol Invest 7:7–13PubMed

111.

Hidaka Y et al (1992) Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 11:239–246PubMed

112.

Wenzel BE, Chow A, Baur R, Schleusener H, Wall JR (1998) Natural killer cell activity in patients with Graves’ disease and Hashimoto’s thyroiditis. Thyroid 8:1019–1022PubMed

113.

Solerte SB (2005) Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol 152:703–712PubMed

114.

Solovera J, Alverez-Mon M, Casas J, Carballido J, Durantez A (1987) Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist. J Immunol 139:876–880PubMed

115.

Weetman AP, Gunn C, Hall R, McGregor AM (1985) The absence of any effect of methimazole on in vitro cell-mediated cytotoxicity. Clin Endocrinol 22:57–64

116.

Solerte SB, Cravello L, Ferrari E, Fioravanti M (2000) Overproduction of IFN-γ and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer’s disease. Ann NY Acad Sci 917:331–340PubMed

Titel: The Role of NK Cells in the Autoimmune Thyroid Disease-associated Pregnancy Loss
verfasst von: Emiliana Konova
Publikationsdatum: 01.12.2010
Verlag: Humana Press Inc
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 3/2010
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-010-8201-7

Neu im Fachgebiet HNO

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

The Role of NK Cells in the Autoimmune Thyroid Disease-associated Pregnancy Loss

Abstract

Neu im Fachgebiet HNO

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Klinikreform soll zehntausende Menschenleben retten

Eingreifen von Umstehenden rettet vor Erstickungstod

Update HNO

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Toll-like Receptors in Pregnancy Disorders and Placental Dysfunction

NK Cells, Autoantibodies, and Immunologic Infertility: A Complex Interplay

Complement Activation and Pregnancy Failure

Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome

Autoimmunity and Recurrent Pregnancy Losses

Does the Immune System Induce Labor? Lessons from Preterm Deliveries in Women with Autoimmune Diseases

Neu im Fachgebiet HNO

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Klinikreform soll zehntausende Menschenleben retten

Eingreifen von Umstehenden rettet vor Erstickungstod

Update HNO